About the journal
Journal for ImmunoTherapy of Cancer is an open-access journal published by BMJ Publishing Group in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 2,390 GBP. Declared review time at DOAJ: 24 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- BMJ Publishing Group
- ISSN
- 2051-1426
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,390 GBP
- Articles in DOAJ
- 7265
- Declared review time
- 24 weeks
- Declared peer-review model
- peer_review
- Official website
- https://jitc.bmj.com
Index listings
- DOAJ · 2013-09-23
- MEDLINE · 2016-01-01
- PUBMED · 2013-08-27
- Indexing
- DOAJ · MEDLINE · PUBMED
- APC
- 2,390 GBP
- Declared review time (DOAJ)
- 24 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
7265
Most recent article
last month
Average review time (journal-declared via DOAJ)
24weeks
Works in OpenAlex
5767
Last recorded publication year
2026
h-index
182
i10-index
3128
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2013-09-23
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- PorticoLOCKSS
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2027
- Level 2 — top tier (~20% of the field's channels)
- Open references deposited at Crossref
- 96%
- ORCID iDs in current deposits
- 94%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- JITC
- Source type
- journal
- NLM unique ID (PubMed)
- 101620585
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- CAR-T cell therapy research
- CAR-T cell therapy research
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
Show all subjects (50)
- Immune cells in cancer
- Immune cells in cancer
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Virus-based gene therapy research
- Virus-based gene therapy research
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- Cancer Research and Treatments
- Cancer Research and Treatments
- T-cell and B-cell Immunology
- T-cell and B-cell Immunology
- vaccines and immunoinformatics approaches
- vaccines and immunoinformatics approaches
- Cancer Genomics and Diagnostics
- Cutaneous Melanoma Detection and Management
- Cancer Genomics and Diagnostics
- Lung Cancer Treatments and Mutations
- Cutaneous Melanoma Detection and Management
- Lung Cancer Treatments and Mutations
- Phagocytosis and Immune Regulation
- Melanoma and MAPK Pathways
- Phagocytosis and Immune Regulation
- Melanoma and MAPK Pathways
- Single-cell and spatial transcriptomics
- Single-cell and spatial transcriptomics
- interferon and immune responses
- interferon and immune responses
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Renal cell carcinoma treatment
- Renal cell carcinoma treatment
- Bladder and Urothelial Cancer Treatments
- Bladder and Urothelial Cancer Treatments
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Treatments and Studies
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Inflammatory Biomarkers in Disease Prognosis
- Inflammatory Biomarkers in Disease Prognosis
Keywords (DOAJ)
- tumour immunology
- cancer immunotherapy
- immunotherapy biomarkers
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ